Shares of Merck & Co. Inc. MRK slumped 0.31% to $99.17 Thursday, on what proved to be an all-around dismal trading session ...

Shares of Merck & Co. Inc. MRK slipped 0.03% to $99.14 Friday, on what proved to be an all-around great trading session for ...

We recently published a list of 8 Best Low Volatility Stocks To Buy Right Now. In this article, we are going to take a look ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Merck & Co.’s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

BMO Capital Markets has recently reduced Merck & Co Inc (MRK) stock to Market Perform rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had ...

Pharma companies Merck & Co. Inc. and Glenmark Pharmaceuticals Ltd. convinced a judge to throw out several claims alleging ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...